Cornelis Jan Stam
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Cornelis Jan Stam has a total of 180 co-authors. Here are the top co-authors by number of shared publications:
- Arjan Hillebrand
Amsterdam Neuroscience, Brain Imaging, Amsterdam, The Netherlands
14 shared publications - Philip Scheltens
Alzheimer Center Amsterdam, Department of Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands; EQT Life Sciences, Amsterdam, Netherlands
8 shared publications - Willem de Haan
Alzheimer Center Amsterdam, Department of Neurology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
6 shared publications - Alida A. Gouw
Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Clinical Neurophysiology and MEG Center, Neurology, De Boelelaan 1117, Amsterdam Netherlands
5 shared publications - Jaap C. Reijneveld
Stichting Epilepsie Instellingen Nederland (SEIN) Heemstede SW the Netherlands
5 shared publications - Anne M. van Nifterick
Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Clinical Neurophysiology and MEG Center, Neurology, De Boelelaan 1117, Amsterdam Netherlands
4 shared publications
Latest Publications
- Open Access
- 27 January 2026
- Published by MIT Press in Imaging Neuroscience
- Vol. 4
Replication and validation of two novel magnetoencephalography functional connectivity measures in Alzheimer’s disease
Two novel magnetoencephalography (MEG) functional connectivity measures were recently shown to be superior to well-known measures of amplitude correlation and phase synchronization in detecting early stage neurophysiological abnormalities, particularly neuronal hyperexcitability, in a computational model of Alzheimer’s disease (AD). The reliability of these measures in empirical data remains to be evaluated. We investigated whether the Phase Lag Time (PLT) and Joint Permutation Entropy (JPE) could identify consistent patterns of between- and within-group functional connectivity in the theta (4–8 Hz), alpha (8–13 Hz), and beta (13–30 Hz) frequency bands in eyes-closed resting-state MEG recordings from two independent cohorts of AD patients (n = 28/n = 29) and control subjects (n = 29/n = 27). We assessed the classification performance of the measures and examined their construct validity using a computational approach. Results were compared with those obtained using two previously validated functional connectivity measures, the leakage-corrected Amplitude Envelope Correlation (AEC-c) and Phase Lag Index (PLI). In both cohorts, whole-brain analysis identified significant group differences (AD patients versus control subjects) in functional connectivity estimated by PLT and JPE across the theta and beta bands (effect sizes: 0.15–0.40; p < .05). Regional analysis revealed that 43–77 regions (out of 80) showed significant group differences in these frequency bands, with significant cross-cohort correlations between regional difference scores of rp = 0.37–0.55, p < .001. PLT and JPE connectivity matrices revealed strong within-group consistency across cohorts for both AD patients and control subjects in all frequency bands (rs > 0.80, p < .001). Logistic regression models trained on whole-brain PLT or JPE values in the theta or beta band achieved area under the curve values between 0.72 and 0.78. Finally, the PLT and JPE were shown to be sensitive to changes in coupling strength in a whole-brain computational model. Across all analyses, the PLT and JPE performed as well as, or better than, the AEC-c and PLI. The PLT and JPE can reliably detect neurophysiological abnormalities related to AD from eyes-closed resting-state MEG recordings. Since accumulating evidence identifies neuronal hyperexcitability as a key pathological process in early AD and a potential therapeutic target, these novel functional connectivity measures could play a valuable role in early disease detection and the evaluation of treatments aimed at restoring the excitation–inhibition balance in AD.
- 27 January 2026
- Published by MIT Press in Imaging Neuroscience
- Vol. 4
Open AccessReplication and validation of two novel magnetoencephalography functional connectivity measures in Alzheimer’s disease
Two novel magnetoencephalography (MEG) functional connectivity measures were recently shown to be superior to well-known measures of amplitude correlation and phase synchronization in detecting early stage neurophysiological abnormalities, particularly neuronal hyperexcitability, in a computational model of Alzheimer’s disease (AD). The reliability of these measures in empirical data remains to be evaluated. We investigated whether the Phase Lag Time (PLT) and Joint Permutation Entropy (JPE) could identify consistent patterns of between- and within-group functional connectivity in the theta (4–8 Hz), alpha (8–13 Hz), and beta (13–30 Hz) frequency bands in eyes-closed resting-state MEG recordings from two independent cohorts of AD patients (n = 28/n = 29) and control subjects (n = 29/n = 27). We assessed the classification performance of the measures and examined their construct validity using a computational approach. Results were compared with those obtained using two previously validated functional connectivity measures, the leakage-corrected Amplitude Envelope Correlation (AEC-c) and Phase Lag Index (PLI). In both cohorts, whole-brain analysis identified significant group differences (AD patients versus control subjects) in functional connectivity estimated by PLT and JPE across the theta and beta bands (effect sizes: 0.15–0.40; p < .05). Regional analysis revealed that 43–77 regions (out of 80) showed significant group differences in these frequency bands, with significant cross-cohort correlations between regional difference scores of rp = 0.37–0.55, p < .001. PLT and JPE connectivity matrices revealed strong within-group consistency across cohorts for both AD patients and control subjects in all frequency bands (rs > 0.80, p < .001). Logistic regression models trained on whole-brain PLT or JPE values in the theta or beta band achieved area under the curve values between 0.72 and 0.78. Finally, the PLT and JPE were shown to be sensitive to changes in coupling strength in a whole-brain computational model. Across all analyses, the PLT and JPE performed as well as, or better than, the AEC-c and PLI. The PLT and JPE can reliably detect neurophysiological abnormalities related to AD from eyes-closed resting-state MEG recordings. Since accumulating evidence identifies neuronal hyperexcitability as a key pathological process in early AD and a potential therapeutic target, these novel functional connectivity measures could play a valuable role in early disease detection and the evaluation of treatments aimed at restoring the excitation–inhibition balance in AD.
- Open Access
- 17 July 2025
- Published by MIT Press in Network Neuroscience
- Vol. 9 (3) , 824-841
Longitudinal changes in MEG-based brain network topology of ALS patients with cognitive/behavioral impairment—An exploratory study
Amyotrophic lateral sclerosis (ALS) with only motor impairment (ALS-pure motor) and the behavioral variant of frontotemporal dementia (bvFTD) are hypothesized to represent extreme ends of a disease spectrum, which encompasses ALS with cognitive/behavioral impairment (ALSci/bi). In this longitudinal magnetoencephalography (MEG) study, we investigated changes in brain network topology of ALSci/bi over time as compared with ALS-pure motor and bvFTD patients. Resting-state MEG was recorded in ALS-pure motor (n = 9), ALSci/bi (n = 16), and bvFTD (n = 16) at baseline and 5-month follow-up, projected to source space. The corrected version of the amplitude envelope correlation was applied to compute frequency-band-specific functional connectivity between brain regions, from which the backbone of the functional networks was constructed using the minimum spanning tree (MST) approach. Reference MSTs were computed based on the functional connectivity matrices for ALS-pure motor and bvFTD, against which the networks of ALSci/bi were compared. We showed that, at baseline, networks in the theta band of ALSci/bi patients were more similar to ALS-pure motor than bvFTD. At follow-up, ALSci/bi patients’ beta-band network similarity had moved away from ALS-pure motor and resembled bvFTD. In conclusion, our findings suggest that brain networks of ALSci/bi patients move along the ALS-bvFTD spectrum over time, from ALS-pure motor to bvFTD-like topology.
- 17 July 2025
- Published by MIT Press in Network Neuroscience
- Vol. 9 (3) , 824-841
Open AccessLongitudinal changes in MEG-based brain network topology of ALS patients with cognitive/behavioral impairment—An exploratory study
Amyotrophic lateral sclerosis (ALS) with only motor impairment (ALS-pure motor) and the behavioral variant of frontotemporal dementia (bvFTD) are hypothesized to represent extreme ends of a disease spectrum, which encompasses ALS with cognitive/behavioral impairment (ALSci/bi). In this longitudinal magnetoencephalography (MEG) study, we investigated changes in brain network topology of ALSci/bi over time as compared with ALS-pure motor and bvFTD patients. Resting-state MEG was recorded in ALS-pure motor (n = 9), ALSci/bi (n = 16), and bvFTD (n = 16) at baseline and 5-month follow-up, projected to source space. The corrected version of the amplitude envelope correlation was applied to compute frequency-band-specific functional connectivity between brain regions, from which the backbone of the functional networks was constructed using the minimum spanning tree (MST) approach. Reference MSTs were computed based on the functional connectivity matrices for ALS-pure motor and bvFTD, against which the networks of ALSci/bi were compared. We showed that, at baseline, networks in the theta band of ALSci/bi patients were more similar to ALS-pure motor than bvFTD. At follow-up, ALSci/bi patients’ beta-band network similarity had moved away from ALS-pure motor and resembled bvFTD. In conclusion, our findings suggest that brain networks of ALSci/bi patients move along the ALS-bvFTD spectrum over time, from ALS-pure motor to bvFTD-like topology.
- 24 September 2024
- Published by Taylor & Francis in Journal of the History of the Neurosciences
- Vol. 34 (3) , 461-471
David Ferrier’s “complex whole”: Early traces of a “brain network” concept
Currently, the idea that the brain is a complex network of interacting brain regions is hardly controversial. The rapid development of this field is often attributed to the emergence of powerful brain-imaging techniques and, around the millennium, the merging of the neuroscience of brain networks with modern mathematical graph theory. However, little is known about the historical roots of this concept. It is interesting to know when the first traces of a concept of brain networks can be found in the work of early neuroscientists, how this concept evolved over time, and what factors may have influenced this evolution. This study aims to set a first step in addressing these questions by a detailed analysis of David Ferrier's classic study, The Functions of the Brain. From this analysis it will become clear that, in addition to a clear notion of localized functions in the brain, Ferrier speculated in several places about the need for several of these brain regions to communicate and interact in order to bring about higher brain functions. He referred to this perspective on the brain as a "complex whole," which could be interpreted as an early precursor of the modern concept of brain networks.
- 24 September 2024
- Published by Taylor & Francis in Journal of the History of the Neurosciences
- Vol. 34 (3) , 461-471
David Ferrier’s “complex whole”: Early traces of a “brain network” concept
Currently, the idea that the brain is a complex network of interacting brain regions is hardly controversial. The rapid development of this field is often attributed to the emergence of powerful brain-imaging techniques and, around the millennium, the merging of the neuroscience of brain networks with modern mathematical graph theory. However, little is known about the historical roots of this concept. It is interesting to know when the first traces of a concept of brain networks can be found in the work of early neuroscientists, how this concept evolved over time, and what factors may have influenced this evolution. This study aims to set a first step in addressing these questions by a detailed analysis of David Ferrier's classic study, The Functions of the Brain. From this analysis it will become clear that, in addition to a clear notion of localized functions in the brain, Ferrier speculated in several places about the need for several of these brain regions to communicate and interact in order to bring about higher brain functions. He referred to this perspective on the brain as a "complex whole," which could be interpreted as an early precursor of the modern concept of brain networks.
- Open Access
- 15 May 2024
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 99 (4) , 1333-1348
Network Hyperexcitability in Early-Stage Alzheimer’s Disease: Evaluation of Functional Connectivity Biomarkers in a Computational Disease Model
Background: There is increasing evidence from animal and clinical studies that network hyperexcitability (NH) may be an important pathophysiological process and potential target for treatment in early Alzheimer’s disease (AD). Measures of functional connectivity (FC) have been proposed as promising biomarkers for NH, but it is unknown which measure has the highest sensitivity for early-stage changes in the excitation/inhibition balance. Objective: We aim to test the performance of different FC measures in detecting NH at the earliest stage using a computational approach. Methods: We use a whole brain computational model of activity dependent degeneration to simulate progressive AD pathology and NH. We investigate if and at what stage four measures of FC (amplitude envelope correlation corrected [AECc], phase lag index [PLI], joint permutation entropy [JPE] and a new measure: phase lag time [PLT]) can detect early-stage AD pathophysiology. Results: The activity dependent degeneration model replicates spectral changes in line with clinical data and demonstrates increasing NH. Compared to relative theta power as a gold standard the AECc and PLI are shown to be less sensitive in detecting early-stage NH and AD-related neurophysiological abnormalities, while the JPE and the PLT show more sensitivity with excellent test characteristics. Conclusions: Novel FC measures, which are better in detecting rapid fluctuations in neural activity and connectivity, may be superior to well-known measures such as the AECc and PLI in detecting early phase neurophysiological abnormalities and in particular NH in AD. These markers could improve early diagnosis and treatment target identification.
- 15 May 2024
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 99 (4) , 1333-1348
Open AccessNetwork Hyperexcitability in Early-Stage Alzheimer’s Disease: Evaluation of Functional Connectivity Biomarkers in a Computational Disease Model
Background: There is increasing evidence from animal and clinical studies that network hyperexcitability (NH) may be an important pathophysiological process and potential target for treatment in early Alzheimer’s disease (AD). Measures of functional connectivity (FC) have been proposed as promising biomarkers for NH, but it is unknown which measure has the highest sensitivity for early-stage changes in the excitation/inhibition balance. Objective: We aim to test the performance of different FC measures in detecting NH at the earliest stage using a computational approach. Methods: We use a whole brain computational model of activity dependent degeneration to simulate progressive AD pathology and NH. We investigate if and at what stage four measures of FC (amplitude envelope correlation corrected [AECc], phase lag index [PLI], joint permutation entropy [JPE] and a new measure: phase lag time [PLT]) can detect early-stage AD pathophysiology. Results: The activity dependent degeneration model replicates spectral changes in line with clinical data and demonstrates increasing NH. Compared to relative theta power as a gold standard the AECc and PLI are shown to be less sensitive in detecting early-stage NH and AD-related neurophysiological abnormalities, while the JPE and the PLT show more sensitivity with excellent test characteristics. Conclusions: Novel FC measures, which are better in detecting rapid fluctuations in neural activity and connectivity, may be superior to well-known measures such as the AECc and PLI in detecting early phase neurophysiological abnormalities and in particular NH in AD. These markers could improve early diagnosis and treatment target identification.
- Top Cited PapersOpen Access
- 1 April 2024
- Published by MIT Press in Network Neuroscience
- Vol. 8 (1) , 1-23
Hub overload and failure as a final common pathway in neurological brain network disorders
Understanding the concept of network hubs and their role in brain disease is now rapidly becoming important for clinical neurology. Hub nodes in brain networks are areas highly connected to the rest of the brain, which handle a large part of all the network traffic. They also show high levels of neural activity and metabolism, which makes them vulnerable to many different types of pathology. The present review examines recent evidence for the prevalence and nature of hub involvement in a variety of neurological disorders, emphasizing common themes across different types of pathology. In focal epilepsy, pathological hubs may play a role in spreading of seizure activity, and removal of such hub nodes is associated with improved outcome. In stroke, damage to hubs is associated with impaired cognitive recovery. Breakdown of optimal brain network organization in multiple sclerosis is accompanied by cognitive dysfunction. In Alzheimer’s disease, hyperactive hub nodes are directly associated with amyloid-beta and tau pathology. Early and reliable detection of hub pathology and disturbed connectivity in Alzheimer’s disease with imaging and neurophysiological techniques opens up opportunities to detect patients with a network hyperexcitability profile, who could benefit from treatment with anti-epileptic drugs.
- 1 April 2024
- Published by MIT Press in Network Neuroscience
- Vol. 8 (1) , 1-23
Top Cited PapersOpen AccessHub overload and failure as a final common pathway in neurological brain network disorders
Understanding the concept of network hubs and their role in brain disease is now rapidly becoming important for clinical neurology. Hub nodes in brain networks are areas highly connected to the rest of the brain, which handle a large part of all the network traffic. They also show high levels of neural activity and metabolism, which makes them vulnerable to many different types of pathology. The present review examines recent evidence for the prevalence and nature of hub involvement in a variety of neurological disorders, emphasizing common themes across different types of pathology. In focal epilepsy, pathological hubs may play a role in spreading of seizure activity, and removal of such hub nodes is associated with improved outcome. In stroke, damage to hubs is associated with impaired cognitive recovery. Breakdown of optimal brain network organization in multiple sclerosis is accompanied by cognitive dysfunction. In Alzheimer’s disease, hyperactive hub nodes are directly associated with amyloid-beta and tau pathology. Early and reliable detection of hub pathology and disturbed connectivity in Alzheimer’s disease with imaging and neurophysiological techniques opens up opportunities to detect patients with a network hyperexcitability profile, who could benefit from treatment with anti-epileptic drugs.
- Open Access
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S21)
Virtual brain model‐guided optimization of transcranial direct current stimulation in Alzheimer’s disease
Background: Non‐invasive brain stimulation techniques such as transcranial direct current stimulation (tDCS) can potentially counteract disrupted local and distributed brain network activity in Alzheimer’s disease (AD) with a beneficial effect on cognition. However, results of tDCS studies in AD up till now are inconsistent, probably partly due to different methodological choices such as electrode placement. We therefore explored tDCS optimization using a virtual brain network model of AD. Our aim was to compare a large, representative set of virtual tDCS intervention setups, to identify and potentially explain the optimal theoretical tDCS electrode positions for reducing or restoring functional network disruption.Method: We simulated 20 tDCS setups in a computational macroscopic dynamic network model of 78 neural masses, coupled according to human structural topology. AD network damage was simulated using an activity‐dependent degeneration algorithm, which produces typical gradual oscillatory slowing and loss of connectivity. Current flow modeling was used to estimate tDCS‐targeted cortical regions for different electrode positions, and excitability of the pyramidal neurons of the corresponding neural masses was modulated to simulate tDCS. Outcome measures were relative power spectral density in the lower (8‐10 Hz) and upper (8‐13 Hz) alpha bands, total spectral power, posterior alpha peak frequency, and connectivity measures phase lag index (PLI) and amplitude envelope correlation (AEC).Result: The performance of different tDCS strategies varied considerably, with best setups temporarily improving all spectral and connectivity outcome measures, while other setups had little to no effect, or even caused network deterioration. The best performing setup involved right parietal anodal stimulation, with a contralateral supraorbital cathode. A clear correlation between the network role of a region (e.g. hub) and its involvement in successful tDCS was not observed.Conclusion: Modeling tDCS produces specific, falsifiable predictions on how to counter disrupted brain dynamics in AD. In follow‐up studies, our general predictions will be compared to those of personalized virtual models, and then validated with tDCS‐magnetoencephalography (MEG) in a clinical AD patient cohort. This modeling‐informed approach can guide and perhaps accelerate tDCS therapy development, as well as enhance our understanding of tDCS effects.
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S21)
Open AccessVirtual brain model‐guided optimization of transcranial direct current stimulation in Alzheimer’s disease
Background: Non‐invasive brain stimulation techniques such as transcranial direct current stimulation (tDCS) can potentially counteract disrupted local and distributed brain network activity in Alzheimer’s disease (AD) with a beneficial effect on cognition. However, results of tDCS studies in AD up till now are inconsistent, probably partly due to different methodological choices such as electrode placement. We therefore explored tDCS optimization using a virtual brain network model of AD. Our aim was to compare a large, representative set of virtual tDCS intervention setups, to identify and potentially explain the optimal theoretical tDCS electrode positions for reducing or restoring functional network disruption.Method: We simulated 20 tDCS setups in a computational macroscopic dynamic network model of 78 neural masses, coupled according to human structural topology. AD network damage was simulated using an activity‐dependent degeneration algorithm, which produces typical gradual oscillatory slowing and loss of connectivity. Current flow modeling was used to estimate tDCS‐targeted cortical regions for different electrode positions, and excitability of the pyramidal neurons of the corresponding neural masses was modulated to simulate tDCS. Outcome measures were relative power spectral density in the lower (8‐10 Hz) and upper (8‐13 Hz) alpha bands, total spectral power, posterior alpha peak frequency, and connectivity measures phase lag index (PLI) and amplitude envelope correlation (AEC).Result: The performance of different tDCS strategies varied considerably, with best setups temporarily improving all spectral and connectivity outcome measures, while other setups had little to no effect, or even caused network deterioration. The best performing setup involved right parietal anodal stimulation, with a contralateral supraorbital cathode. A clear correlation between the network role of a region (e.g. hub) and its involvement in successful tDCS was not observed.Conclusion: Modeling tDCS produces specific, falsifiable predictions on how to counter disrupted brain dynamics in AD. In follow‐up studies, our general predictions will be compared to those of personalized virtual models, and then validated with tDCS‐magnetoencephalography (MEG) in a clinical AD patient cohort. This modeling‐informed approach can guide and perhaps accelerate tDCS therapy development, as well as enhance our understanding of tDCS effects.
- Open Access
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S17)
Neurophysiological alterations in mice and humans carrying mutations in APP and PSEN1 genes
Background: Studies in animal models of Alzheimer’s disease (AD) have provided valuable insights into the molecular and cellular processes underlying neuronal network dysfunction, but whether and how AD‐related neurophysiological alterations translate between mice and men remains uncertain.Method: We characterized neurophysiological alterations in mice and humans carrying AD mutations in the APP and/or PSEN1 genes, focusing on early changes. Longitudinal local field potential recordings were peformed in 3‐12‐month‐old APP/PS1 mice and cross‐sectional magnetoencephalography recordings in pre‐symptomatic human APP and PSEN1 mutation carriers. Recordings were acquired of the left hippocampus, frontal and parietal cortex. We performed spectral activity and functional connectivity analyses and results were compared with wildtype control mice and healthy age‐matched human subjects.Result: APP/PS1 mice showed increased aboslute power, especially at higher frequencies (beta and gamma) and predominantly between 3 and 6 months of age. Relative power showed an overall shift from lower to higher fequencies over almost the entire recording period and across all three brain regions. There was a trend for reduced peak frequency in APP/PS1 mice at 3‐4 months of age. Human mutation carriers did not show changes in power except for an increase in relative theta power in the hippocampus. Parietal cortex and hippocampal peak frequency were reduced in human mutation carriers. In both models, significant alteration in functional connectivity were detected in theta, alpha, beta and gamma frequency bands, but the exact frequency range and direction of change differed for APP/PS1 mice and human mutation carriers (Table 1).Conclusion: In conclusion, both mice and humans carrying APP and/or PSEN1 mutations show abnormal neurophysiological activity, but several measures do not translate one‐to‐one between species. Alterations in spectral characteristics and functional connectivity in mice should be interpreted with care and may be due to overexpression of amyloid in combination with absence of tau pathology in cholinergic degeneration. Future studies should explore whether changes in brain activity in other AD mouse models provide better translation to the human AD continuum.
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S17)
Open AccessNeurophysiological alterations in mice and humans carrying mutations in APP and PSEN1 genes
Background: Studies in animal models of Alzheimer’s disease (AD) have provided valuable insights into the molecular and cellular processes underlying neuronal network dysfunction, but whether and how AD‐related neurophysiological alterations translate between mice and men remains uncertain.Method: We characterized neurophysiological alterations in mice and humans carrying AD mutations in the APP and/or PSEN1 genes, focusing on early changes. Longitudinal local field potential recordings were peformed in 3‐12‐month‐old APP/PS1 mice and cross‐sectional magnetoencephalography recordings in pre‐symptomatic human APP and PSEN1 mutation carriers. Recordings were acquired of the left hippocampus, frontal and parietal cortex. We performed spectral activity and functional connectivity analyses and results were compared with wildtype control mice and healthy age‐matched human subjects.Result: APP/PS1 mice showed increased aboslute power, especially at higher frequencies (beta and gamma) and predominantly between 3 and 6 months of age. Relative power showed an overall shift from lower to higher fequencies over almost the entire recording period and across all three brain regions. There was a trend for reduced peak frequency in APP/PS1 mice at 3‐4 months of age. Human mutation carriers did not show changes in power except for an increase in relative theta power in the hippocampus. Parietal cortex and hippocampal peak frequency were reduced in human mutation carriers. In both models, significant alteration in functional connectivity were detected in theta, alpha, beta and gamma frequency bands, but the exact frequency range and direction of change differed for APP/PS1 mice and human mutation carriers (Table 1).Conclusion: In conclusion, both mice and humans carrying APP and/or PSEN1 mutations show abnormal neurophysiological activity, but several measures do not translate one‐to‐one between species. Alterations in spectral characteristics and functional connectivity in mice should be interpreted with care and may be due to overexpression of amyloid in combination with absence of tau pathology in cholinergic degeneration. Future studies should explore whether changes in brain activity in other AD mouse models provide better translation to the human AD continuum.
- Open Access
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S14)
Hub vulnerability and short path length to entorhinal cortex are associated with tau binding in Alzheimer’s disease: a combined MEG/PET study
Background: Brain network studies have revealed that highly connected ‘hub’ regions are particularly vulnerable to Alzheimer’s disease (AD) pathology. Additionally, the ‘‘transneuronal spread” hypothesis proposes that a toxic agent (tau) propagates along shortest paths through functionally connected neurons, driven by aberrant neuronal activity. We investigate whether network characteristics as determined using magnetoencephalography (MEG) are correlated to tau pathology in the different stages of AD.Method: We analysed source‐reconstructed MEG data and dynamic 100‐minutes [18F]flortaucipir PET from 57 subjects positive for amyloid‐beta (Aβ)‐pathology (preclinical AD (n = 16)), mild cognitive impairment (MCI (n = 16)) and AD dementia (n = 25)). Cognitively healthy subjects without Aβ‐pathology were included as controls (n = 25). For each subject, we obtained a network based on the alpha band amplitude envelope correlation (AEC‐c, 8‐13Hz), and theta band phase lag index (PLI, 4‐8Hz), based on the Brainnettome atlas. For each node in the network, we obtained the following measures: weighted degree, degree, betweenness centrality, eccentricity (as measures of hubness); distance to left entorhinal cortex (measure of shortest path/transneuronal spread); hub disruption index for all previous hubness measures (selective hub damage) and [18F]flortaucipir BPND. Pearson’s correlations were calculated between group averages of network measures and tau‐PET binding (FDR‐corrected). Furthermore, we analysed whether network measures of the previous disease stage correlated with [18F]flortaucipir retention in the subsequent disease stage.Result: Hub regions were predominantly found in the temporal areas (Fig‐1). Higher ‘hubness’ and shorter neuronal distance to epicentre were associated to higher tau binding in all stages of the AD continuum (Fig‐2a). Disproportional disruption to hub regions in the AEC‐c alpha band was associated with increased tau binding, but the opposite effect was found for the PLI theta band (Fig‐2b). Finally, high weighted degree, degree, and betweenness centrality in the preceding disease stage were correlated with increased tau binding in subsequent disease stages (Fig‐2c).Conclusion: Hub regions and transneuronal spreading are key mechanisms in the propagation of tau pathology across the AD brain. Furthermore, hubs are particularly vulnerable to tau. The insight that high neuronal activity might play a causal role in Alzheimer’s disease can have implications for early detection and interventional strategies.
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S14)
Open AccessHub vulnerability and short path length to entorhinal cortex are associated with tau binding in Alzheimer’s disease: a combined MEG/PET study
Background: Brain network studies have revealed that highly connected ‘hub’ regions are particularly vulnerable to Alzheimer’s disease (AD) pathology. Additionally, the ‘‘transneuronal spread” hypothesis proposes that a toxic agent (tau) propagates along shortest paths through functionally connected neurons, driven by aberrant neuronal activity. We investigate whether network characteristics as determined using magnetoencephalography (MEG) are correlated to tau pathology in the different stages of AD.Method: We analysed source‐reconstructed MEG data and dynamic 100‐minutes [18F]flortaucipir PET from 57 subjects positive for amyloid‐beta (Aβ)‐pathology (preclinical AD (n = 16)), mild cognitive impairment (MCI (n = 16)) and AD dementia (n = 25)). Cognitively healthy subjects without Aβ‐pathology were included as controls (n = 25). For each subject, we obtained a network based on the alpha band amplitude envelope correlation (AEC‐c, 8‐13Hz), and theta band phase lag index (PLI, 4‐8Hz), based on the Brainnettome atlas. For each node in the network, we obtained the following measures: weighted degree, degree, betweenness centrality, eccentricity (as measures of hubness); distance to left entorhinal cortex (measure of shortest path/transneuronal spread); hub disruption index for all previous hubness measures (selective hub damage) and [18F]flortaucipir BPND. Pearson’s correlations were calculated between group averages of network measures and tau‐PET binding (FDR‐corrected). Furthermore, we analysed whether network measures of the previous disease stage correlated with [18F]flortaucipir retention in the subsequent disease stage.Result: Hub regions were predominantly found in the temporal areas (Fig‐1). Higher ‘hubness’ and shorter neuronal distance to epicentre were associated to higher tau binding in all stages of the AD continuum (Fig‐2a). Disproportional disruption to hub regions in the AEC‐c alpha band was associated with increased tau binding, but the opposite effect was found for the PLI theta band (Fig‐2b). Finally, high weighted degree, degree, and betweenness centrality in the preceding disease stage were correlated with increased tau binding in subsequent disease stages (Fig‐2c).Conclusion: Hub regions and transneuronal spreading are key mechanisms in the propagation of tau pathology across the AD brain. Furthermore, hubs are particularly vulnerable to tau. The insight that high neuronal activity might play a causal role in Alzheimer’s disease can have implications for early detection and interventional strategies.
- Open Access
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S21)
Longitudinal resting‐state EEG along the Alzheimer’s disease continuum: Sample size considerations for clinical trials.
Background: To enable successful inclusion of resting‐state electroencephalography (EEG) outcome measures in Alzheimer’s disease (AD) clinical trials, we (retrospectively) mapped the progression of EEG markers over time in amyloid‐positive subjects.Methods: Resting‐state 21‐channel EEG was recorded in 173 subjects positive for amyloid deposition (subjective cognitive decline, n = 16; mild cognitive impairment, n = 94; dementia due to AD, n = 63). Two or more EEG recordings were available for all subjects. We computed whole‐brain and regional relative power (i.e., theta (4‐8Hz), alpha1 (8‐10Hz), alpha2 (10‐13Hz), beta (13‐30Hz)), peak frequency, signal variability (i.e., theta Permutation Entropy) and functional connectivity values (i.e., alpha and beta corrected Amplitude Envelope Correlation, theta Phase Lag Index, weighted Symbolic Mutual Information, inverted Joint Permutation Entropy). Whole‐group linear mixed effects models were used to model the development of EEG markers over time. Group‐wise analysis was performed to investigate potential differences in change trajectories between diagnostic groups. The longitudinal relation between EEG and cognition was evaluated. Finally, we estimated the minimum sample size required to detect a stabilizing treatment effect using EEG markers, in hypothetical clinical trials of 1‐ or 2‐year duration.Results: Whole‐group analysis revealed significant regional and global oscillatory slowing over time (i.e., increased relative theta power, decreased alpha2 and beta power), with strongest effects for temporal and parieto‐occipital regions. Signal variability showed stronger decline on a global scale. We report no significant longitudinal changes in functional connectivity strength. Disease severity at baseline influenced EEG markers’ rates of change, with fastest deterioration in MCI subjects. A decrease of the parieto‐occipital peak frequency, temporal relative alpha2 and beta power, as well as an increase in temporal relative theta power, were significantly associated with a decline in Mini Mental State Examination score. We estimate that 1‐year trials, focusing on amyloid‐positive MCI subjects, require 148 or 438 subjects per arm to detect a stabilizing treatment effect on temporal relative theta‐ or beta power, respectively.Conclusion: Resting‐state EEG markers can facilitate early detection of target engagement in an objective, non‐invasive, low‐cost manner. Spectral measures, particularly recorded from temporal regions, present robust secondary endpoints for AD interventions.
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S21)
Open AccessLongitudinal resting‐state EEG along the Alzheimer’s disease continuum: Sample size considerations for clinical trials.
Background: To enable successful inclusion of resting‐state electroencephalography (EEG) outcome measures in Alzheimer’s disease (AD) clinical trials, we (retrospectively) mapped the progression of EEG markers over time in amyloid‐positive subjects.Methods: Resting‐state 21‐channel EEG was recorded in 173 subjects positive for amyloid deposition (subjective cognitive decline, n = 16; mild cognitive impairment, n = 94; dementia due to AD, n = 63). Two or more EEG recordings were available for all subjects. We computed whole‐brain and regional relative power (i.e., theta (4‐8Hz), alpha1 (8‐10Hz), alpha2 (10‐13Hz), beta (13‐30Hz)), peak frequency, signal variability (i.e., theta Permutation Entropy) and functional connectivity values (i.e., alpha and beta corrected Amplitude Envelope Correlation, theta Phase Lag Index, weighted Symbolic Mutual Information, inverted Joint Permutation Entropy). Whole‐group linear mixed effects models were used to model the development of EEG markers over time. Group‐wise analysis was performed to investigate potential differences in change trajectories between diagnostic groups. The longitudinal relation between EEG and cognition was evaluated. Finally, we estimated the minimum sample size required to detect a stabilizing treatment effect using EEG markers, in hypothetical clinical trials of 1‐ or 2‐year duration.Results: Whole‐group analysis revealed significant regional and global oscillatory slowing over time (i.e., increased relative theta power, decreased alpha2 and beta power), with strongest effects for temporal and parieto‐occipital regions. Signal variability showed stronger decline on a global scale. We report no significant longitudinal changes in functional connectivity strength. Disease severity at baseline influenced EEG markers’ rates of change, with fastest deterioration in MCI subjects. A decrease of the parieto‐occipital peak frequency, temporal relative alpha2 and beta power, as well as an increase in temporal relative theta power, were significantly associated with a decline in Mini Mental State Examination score. We estimate that 1‐year trials, focusing on amyloid‐positive MCI subjects, require 148 or 438 subjects per arm to detect a stabilizing treatment effect on temporal relative theta‐ or beta power, respectively.Conclusion: Resting‐state EEG markers can facilitate early detection of target engagement in an objective, non‐invasive, low‐cost manner. Spectral measures, particularly recorded from temporal regions, present robust secondary endpoints for AD interventions.
- Open Access
- 12 May 2023
- Published by Springer Nature in Brain Topography
- Vol. 36 (4) , 595-612
Network Hyperexcitability in Early Alzheimer’s Disease: Is Functional Connectivity a Potential Biomarker?
Network hyperexcitability (NH) is an important feature of the pathophysiology of Alzheimer’s disease. Functional connectivity (FC) of brain networks has been proposed as a potential biomarker for NH. Here we use a whole brain computational model and resting-state MEG recordings to investigate the relation between hyperexcitability and FC. Oscillatory brain activity was simulated with a Stuart Landau model on a network of 78 interconnected brain regions. FC was quantified with amplitude envelope correlation (AEC) and phase coherence (PC). MEG was recorded in 18 subjects with subjective cognitive decline (SCD) and 18 subjects with mild cognitive impairment (MCI). Functional connectivity was determined with the corrected AECc and phase lag index (PLI), in the 4–8 Hz and the 8–13 Hz bands. The excitation/inhibition balance in the model had a strong effect on both AEC and PC. This effect was different for AEC and PC, and was influenced by structural coupling strength and frequency band. Empirical FC matrices of SCD and MCI showed a good correlation with model FC for AEC, but less so for PC. For AEC the fit was best in the hyperexcitable range. We conclude that FC is sensitive to changes in E/I balance. The AEC was more sensitive than the PLI, and results were better for the thetaband than the alpha band. This conclusion was supported by fitting the model to empirical data. Our study justifies the use of functional connectivity measures as surrogate markers for E/I balance.
- 12 May 2023
- Published by Springer Nature in Brain Topography
- Vol. 36 (4) , 595-612
Open AccessNetwork Hyperexcitability in Early Alzheimer’s Disease: Is Functional Connectivity a Potential Biomarker?
Network hyperexcitability (NH) is an important feature of the pathophysiology of Alzheimer’s disease. Functional connectivity (FC) of brain networks has been proposed as a potential biomarker for NH. Here we use a whole brain computational model and resting-state MEG recordings to investigate the relation between hyperexcitability and FC. Oscillatory brain activity was simulated with a Stuart Landau model on a network of 78 interconnected brain regions. FC was quantified with amplitude envelope correlation (AEC) and phase coherence (PC). MEG was recorded in 18 subjects with subjective cognitive decline (SCD) and 18 subjects with mild cognitive impairment (MCI). Functional connectivity was determined with the corrected AECc and phase lag index (PLI), in the 4–8 Hz and the 8–13 Hz bands. The excitation/inhibition balance in the model had a strong effect on both AEC and PC. This effect was different for AEC and PC, and was influenced by structural coupling strength and frequency band. Empirical FC matrices of SCD and MCI showed a good correlation with model FC for AEC, but less so for PC. For AEC the fit was best in the hyperexcitable range. We conclude that FC is sensitive to changes in E/I balance. The AEC was more sensitive than the PLI, and results were better for the thetaband than the alpha band. This conclusion was supported by fitting the model to empirical data. Our study justifies the use of functional connectivity measures as surrogate markers for E/I balance.